mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
4e-16 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
8e-15 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
7e-14 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.37 |
1e-13 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
4e-12 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-11 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-10 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-10 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-10 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-10 |